☆ 4.7 Article

Calcium and zinc tune autoinflammatory Toll-like receptor 4 signaling by S100A12

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)

Journal

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Volume 142, Issue 4, Pages 1370-+

Publisher

MOSBY-ELSEVIER

DOI: 10.1016/j.jaci.2018.06.027

Keywords

Funding

Muenster University medical faculty [KE121201]
German Research Foundation (DFG) [WI3176/2-1, Fo354/3-1]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Toll-Like Receptor 4 Inhibits Estradiol Secretion via NF-κB Signaling in Human Granulosa Cells

Hai-Yun Guan, He-Xia Xia, Xiu-Ying Chen, Lu Wang, Zhi-Jing Tang, Wei Zhang

Summary: The activation of TLR4 was found to suppress CYP19A1 expression and E2 secretion in human granulosa cells via NF-κB signaling, which has implications for follicular development and estrogen synthesis regulation.

FRONTIERS IN ENDOCRINOLOGY (2021)

Add to Collection

Article Pharmacology & Pharmacy

Glucagon-Like Peptide-1 Analog Exendin-4 Ameliorates Cocaine-Mediated Behavior by Inhibiting Toll-Like Receptor 4 Signaling in Mice

Changliang Zhu, Hong Tao, Shikuo Rong, Lifei Xiao, Xinxiao Li, Shucai Jiang, Baorui Guo, Lei Wang, Jiangwei Ding, Caibing Gao, Haigang Chang, Tao Sun, Feng Wang

Summary: Exendin-4 was effective in inhibiting cocaine-induced CPP, facilitating the extinction of cocaine-associated reward, and attenuating reinstatement of cocaine-induced behavior. These effects may be attributed to the inhibition of TLR4, TNF-alpha, and IL-1 beta expression.

FRONTIERS IN PHARMACOLOGY (2021)

Add to Collection

Article Neurosciences

Toll-Like Receptor 4 Signaling in Neurons Mediates Cerebral Ischemia/Reperfusion Injury

Liang Liu, Tian-Ce Xu, Zi-Ai Zhao, Nan-Nan Zhang, Jing Li, Hui-Sheng Chen

Summary: TLR4 signaling in neurons plays a crucial role in neuronal death and neuroinflammatory responses following brain ischemia. Deletion of TLR4 reduces neuronal death and intracellular Ca2+ influx induced by oxygen and glucose deprivation or lipopolysaccharide treatment. TLR4 interacts with NMDAR2B and affects the interaction between nNOS and PSD-95, contributing to ischemic injury.

MOLECULAR NEUROBIOLOGY (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Trimebutine suppresses Toll-like receptor 2/4/7/8/9 signaling pathways in macrophages

Natsumi Ogawa, Shingo Nakajima, Kenya Tamada, Natsuki Yokoue, Haruki Tachibana, Miwa Okazawa, Takahiro Oyama, Hideaki Abe, Hiroaki Yamazaki, Atsushi Yoshimori, Akira Sato, Takanori Kamiya, Takehiko Yokomizo, Fumiaki Uchiumi, Takehiko Abe, Sei-ichi Tanuma

Summary: The spasmolytic drug trimebutine has shown potential as an anti-inflammatory agent in experiments, reducing the production of various proinflammatory factors and significantly decreasing mortality in a mouse model of sepsis. Studies have found that trimebutine exerts its anti-inflammatory effects by inhibiting TLR signaling pathways and NF-kappa B activity.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2021)

Add to Collection

Review Critical Care Medicine

Toll-Like Receptors, Associated Biochemical Signaling Networks, and S100 Ligands

Sahil Gupta, James N. Tsoporis, Song-Hui Jia, Claudia C. dos Santos, Thomas G. Parker, John C. Marshall

Summary: This article discusses how host cells recognize danger signals using pattern recognition receptors, focusing on Toll-like receptors (TLRs) as the most studied class of PRRs. It reviews the expression, regulation, and function of different TLRs, emphasizing TLR-4, and how TLR adaptor protein binding directs intracellular signaling to activate or terminate an innate immune response. The recent progress in research on the involvement of S100 proteins as ligands for TLR-4 in inflammatory disease is also highlighted.

SHOCK (2021)

Add to Collection

Article Immunology

Innate/Inflammatory Bioregulation of Surfactant Protein D Alleviates Rat Osteoarthritis by Inhibiting Toll-Like Receptor 4 Signaling

Huanyu Jiang, Yubiao Zhang, Geliang Hu, Xiaobin Shang, Jianghua Ming, Ming Deng, Yaming Li, Yonggang Ma, Shiqing Liu, Yan Zhou

Summary: The study reveals the important role of surfactant protein D (SP-D) in regulating inflammation and immune response in osteoarthritis (OA). SP-D exhibits chondroprotective properties by downregulating inflammation-related genes, suppressing cytokine production, and reducing infiltration of inflammatory cells. The binding of SP-D to the TLR4/MD-2 complex further inhibits TLR4-mediated signaling activation. These findings suggest that SP-D has a beneficial effect in attenuating inflammation and preserving cartilage integrity in OA.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Cell Biology

Hemoglobin increases leukocyte adhesion and initiates lung microvascular endothelial activation via Toll-like receptor 4 signaling

Adrienne K. Conger, Toria Tomasek, Kyle J. Riedmann, Joel S. Douglas, Lucia E. Berkey, Lorraine B. Ware, Julie A. Bastarache, Jamie E. Meegan

Summary: Cell-free hemoglobin is involved in endothelial injury during sepsis and ARDS, but the underlying mechanisms remain unclear. In this study, it was found that hemoglobin increased leukocyte adhesion and endothelial activation in HLMVEC through TLR4 signaling, resulting in transcriptional upregulation of inflammatory cytokines and adhesion molecules. Furthermore, hemoglobin-induced NF-κB activation and ROS production were also mediated by TLR4.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2023)

Add to Collection

Review Immunology

Signaling Through Nucleic Acid Sensors and Their Roles in Inflammatory Diseases

Haruna Okude, Daisuke Ori, Taro Kawai

Summary: Recognition of pathogen-derived nucleic acids by PRRs is crucial for antiviral immune responses, but abnormal recognition of self-nucleic acids by PRRs is associated with autoimmune diseases.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Review Biotechnology & Applied Microbiology

Antimicrobial peptides could antagonize uncontrolled inflammation via Toll-like 4 receptor

Danieli F. Buccini, Beatriz C. Roriz, Julia M. Rodrigues, Octavio L. Franco

Summary: Antimicrobial peptides are important molecules in the organism's defense system. They can modulate the immune system and recognize molecules present in pathogens. Overstimulation of TLR4 can lead to uncontrolled inflammatory responses, which can be counteracted by antimicrobial peptides.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2022)

Add to Collection

Article Cell Biology

Deep Succinylproteomics of Brain Tissues from Intracerebral Hemorrhage with Inhibition of Toll-Like Receptor 4 Signaling

Yan-Jing Liang, Yuan-Rui Yang, Chuan-Yuan Tao, Su-Hao Yang, Xin-Xiao Zhang, Jing Yuan, Yuan-Hong Deng, Zhan-Qiong Zhong, Shu-Guang Yu, Xiao-Yi Xiong

Summary: The study revealed that TLR4 signaling pathways affect protein succinylation processes in mouse ICH brains, with TAK242 treatment leading to both increased and decreased succinyllysine sites in the brain. These changes were mainly located in the mitochondria and cytoplasm of the cells.

CELLULAR AND MOLECULAR NEUROBIOLOGY (2022)

Add to Collection

Article Gastroenterology & Hepatology

Fecal microbiota transplantation alleviates experimental colitis through the Toll-like receptor 4 signaling pathway

Xin Wen, Rui Xie, Hong-Gang Wang, Min-Na Zhang, Le He, Meng-Hui Zhang, Xiao-Zhong Yang

Summary: This study investigated the mechanism of fecal microbiota transplantation (FMT) in treating ulcerative colitis (UC) through association analysis of gut microbiota with colon transcriptome in mice. The results revealed that FMT regulates the Toll-like receptor 4 (TLR4) signaling pathway, microbiota composition, and related gene expression to ameliorate colitis and maintain intestinal stability.

WORLD JOURNAL OF GASTROENTEROLOGY (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Hepatocyte Toll-Like Receptor 4 Mediates Alcohol-Induced Insulin Resistance in Mice

Piumi B. Wickramasinghe, Shuwen Qian, Lyndsey E. Langley, Chen Liu, Lin Jia

Summary: Accumulating evidence suggests that alcohol overconsumption is associated with insulin resistance, and this study investigated the role of hepatocyte toll-like receptor 4 (TLR4) in alcohol-induced insulin resistance. The findings indicate that hepatocyte TLR4 is both required and sufficient for the development of insulin resistance caused by alcohol overconsumption.

BIOMOLECULES (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Toll-like Receptor 4 Inflammatory Perspective on Doxorubicin-Induced Cardiotoxicity

Natticha Sumneang, Pongpan Tanajak, Thura Tun Oo

Summary: Doxorubicin (Dox) is commonly used chemotherapeutic drug, but its cardiotoxicity reduces its therapeutic efficacy. Dox-induced cardiac inflammation is considered as one of the underlying mechanisms involved in Dox-induced cardiotoxicity. Understanding the role of the Toll-like receptor 4 (TLR4) signaling pathway in Dox-induced cardiac inflammation might be beneficial for developing potential therapeutic strategies.

MOLECULES (2023)

Add to Collection

Article Chemistry, Medicinal

Toll-like receptor 4 (TLR4) inhibitors: Current research and prospective

Yongsheng Zhang, Xinjie Liang, Xuefei Bao, Wei Xiao, Guoliang Chen

Summary: This review discusses TLR4 inhibitors that can bind directly to TLR4 or the TLR4/MD2 complex, as well as compounds that can downregulate the expression of TLR4. The involvement of specific residues in the binding of antagonistic ligands to the TLR4/MD2 complex provides useful information for structure-based TLR4 inhibitor design.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Add to Collection

Article Plant Sciences

Ginsenoside Ro, an oleanolic saponin of Panax ginseng, exerts anti-inflammatory effect by direct inhibiting toll like receptor 4 signaling pathway

Hong-Lin Xu, Guang-Hong Chen, Yu-Ting Wu, Ling-Peng Xie, Zhang-Bin Tan, Bin Liu, Hui-Jie Fan, Hong-Mei Chen, Gui-Qiong Huang, Min Liu, Ying-Chun Zhou

Summary: This study explored the anti-inflammatory effects of Panax ginseng and identified ginsenoside Ro (GRo) as an active component that directly inhibits the TLR4 signaling pathway.

JOURNAL OF GINSENG RESEARCH (2022)

Add to Collection

Article Allergy

Therapeutic options for CTLA-4 insufficiency

David Egg, Ina Caroline Rump, Noriko Mitsuiki, Jessica Rojas-Restrepo, Maria-Elena Maccari, Charlotte Schwab, Annemarie Gabrysch, Klaus Warnatz, Sigune Goldacker, Virginia Patino, Daniel Wolff, Satoshi Okada, Seiichi Hayakawa, Yoshiaki Shikama, Kenji Kanda, Kohsuke Imai, Manabu Sotomatsu, Makoto Kuwashima, Takahiro Kamiya, Tomohiro Morio, Kazuaki Matsumoto, Takeshi Mori, Yuri Yoshimoto, Ingunn Dybedal, Maria Kanariou, Zeynep Yesim Kucuk, Hugo Chapdelaine, Lenka Petruzelkova, Hanns-Martin Lorenz, Kathleen E. Sullivan, Jennifer Heimall, Michel Moutschen, Jiri Litzman, Mike Recher, Michael H. Albert, Fabian Hauck, Suranjith Seneviratne, Jana Pachlopnik Schmid, Antonios Kolios, Gary Unglik, Christian Klemann, Scott Snapper, Lisa Giulino-Roth, Michael Svaton, Craig D. Platt, Sophie Hambleton, Olaf Neth, Geraldine Gosse, Steffen Reinsch, Dirk Holzinger, Yae-Jean Kim, Shahrzad Bakhtiar, Faranaz Atschekzei, Reinhold Schmidt, Georgios Sogkas, Shanmuganathan Chandrakasan, William Rae, Beata Derfalvi, Hanne Vibeke Marquart, Ahmet Ozen, Ayca Kiykim, Elif Karakoc-Aydiner, Pavlina Kralickova, Godelieve de Bree, Dimitra Kiritsi, Markus G. Seidel, Robin Kobbe, Jennifer Dantzer, Laia Alsina, Thais Armangue, Vassilios Lougaris, Philipp Agyeman, Sofia Nystrom, David Buchbinder, Peter D. Arkwright, Bodo Grimbacher

Summary: Heterozygous germline mutations in cytotoxic T lymphocyte-associated antigen-4 (CTLA4) can lead to life-threatening autoimmune and lymphoproliferative complications. Treatment options include systemic immunosuppressants, immunoglobulin replacement, and stem cell transplantation for potential cure.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Add to Collection

Article Allergy

Rubella vaccine-induced granulomas are a novel phenotype with incomplete penetrance of genetic defects in cytotoxicity

Miriam Gross, Carsten Speckmann, Annette May, Tania Gajardo-Carrasco, Katharina Wustrau, Sarah Lena Maier, Marcus Panning, Daniela Huzly, Abbas Agaimy, Yenan T. Bryceson, Sharon Choo, C. W. Chow, Gregor Dueckers, Anders Fasth, Sylvie Fraitag, Katja Graewe, Sabine Haxelmans, Dirk Holzinger, Ole Hudowenz, Judith M. Huebschen, Claudia Khurana, Korbinian Kienle, Roman Klifa, Klaus Korn, Heinz Kutzner, Tim Laemmermann, Svea Ledig, Dan Lipsker, Marie Meeths, Nora Naumann-Bartsch, Jelena Rascon, Anne Schaenzer, Maximilian Seidl, Bianca Tesi, Christelle Vauloup-Fellous, Beate Vollmer-Kary, Klaus Warnatz, Claudia Wehr, Benedicte Neven, Pablo Vargas, Fernando E. Sepulveda, Kai Lehmberg, Annette Schmitt-Graeff, Stephan Ehl

Summary: This study investigated the defective effector mechanism allowing rubella vaccine virus persistence in granulomas by studying patients with cytotoxicity defects and granuloma. The results suggest a critical role of T cells in rubella elimination.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Add to Collection

Article Rheumatology

MRP8/14 serum levels as diagnostic markers for systemic juvenile idiopathic arthritis in children with prolonged fever

Carolin Park, Maria Miranda-Garcia, Rainer Berendes, Gerd Horneff, Jasmin Kuemmerle-Deschner, Gerd Ganser, Hans-Iko Huppertz, Kirsten Minden, Johannes-Peter Haas, Annette F. Jansson, Michael Borte, Catharina Schuetz, Prasad Oommen, Michael Frosch, Bernhard Schlueter, Annette Richter-Unruh, Christoph Kessel, Claas Hinze, Helmut Wittkowski, Johannes Roth, Dirk Foell, Dirk Holzinger

Summary: This study validated the usefulness of MRP8/14 serum analyses in supporting the diagnosis of SJIA in febrile children. The results could be confirmed with commercial ELISA and LFIA, enabling a rapid diagnostic point-of-care screening test.

RHEUMATOLOGY (2022)

Add to Collection

Article Rheumatology

Prevention of disease flares by risk-adapted stratification of therapy withdrawal in juvenile idiopathic arthritis: results from the PREVENT-JIA trial

Joachim Gerss, Monika Tedy, Ariane Klein, Gerd Horneff, Maria Miranda-Garcia, Christoph Kessel, Dirk Holzinger, Valda Stanevica, Joost F. Swart, David A. Cabral, Hermine Brunner, Dirk Foell

Summary: This study investigates the use of high-sensitivity C-reactive protein (hsCRP) and S100A12 as predictive biomarkers for successful drug withdrawal in children with clinical remission of juvenile idiopathic arthritis (JIA). The results show that using these predictive markers of subclinical inflammation is a promising tool in the decision-making process of therapy withdrawal, resulting in direct benefit for patients.

ANNALS OF THE RHEUMATIC DISEASES (2022)

Add to Collection

Article Rheumatology

Use of MRP8/14 in clinical practice as a predictor of outcome after methotrexate withdrawal in patients with juvenile idiopathic arthritis

Emma J. Sumner, Beverley Almeida, Jason Palman, Peter Bale, Clare Heard, Dirk Holzinger, Johannes Roth, Dirk Foell, Emily Robinson, Simona Ursu, Chris Wallace, Kimberly Gilmour, Lucy R. Wedderburn, Elizabeth Ralph

Summary: The objective of this study was to determine the effectiveness of MRP8/14 as a predictor of disease flare in patients with juvenile idiopathic arthritis (JIA) following the withdrawal of methotrexate (MTX) in a routine clinical setting. The study found that there was no significant difference in flares between patients with an elevated or low MRP8/14 value. However, in those who stopped MTX, no patients with a low MRP8/14 result flared.

CLINICAL RHEUMATOLOGY (2022)

Add to Collection

Article Rheumatology

Soluble interleukin-2 receptor serum levels facilitate prediction of relapses in subgroups of patients with juvenile idiopathic arthritis

Linda Ziegler, Sabrina Fuehner, Christoph Kessel, Claas Hinze, Jens Klotsche, Martina Niewerth, Kirsten Minden, Dirk Foell

Summary: This study investigated the changes in serum biomarkers during inactive disease in JIA patients to evaluate their usefulness in identifying patients at risk for disease relapse. The results showed that sIL-2R serum levels were significantly higher in patients with future active disease, particularly in certain subtypes of JIA. Higher sIL-2R serum levels during inactive disease may help identify patients with subclinical disease activity at risk for future active disease, compared to conventional inflammation parameters.

RHEUMATOLOGY (2022)

Add to Collection

Article Pediatrics

Working Towards a Treat-to-Target Protocol in Juvenile Proliferative Lupus Nephritis - A Survey of Pediatric Rheumatologists and Nephrologists in Germany and Austria

Kristina Vollbach, Catharina Schuetz, Christian M. Hedrich, Fabian Speth, Kirsten Moenkemoeller, Juergen Brunner, Ulrich Neudorf, Christoph Rietschel, Anton Hospach, Tilmann Kallinich, Claas Hinze, Norbert Wagner, Burkhard Toenshoff, Lutz T. Weber, Kay Latta, Julia Thumfart, Martin Bald, Dagobert Wiemann, Hildegard Zappel, Klaus Tenbrock, Dieter Haffner

Summary: The majority of pediatric rheumatologists and nephrologists in Germany and Austria recommend the use of corticosteroids, typically in combination with either MMF or CP, for the treatment of proliferative LN in children. The heterogeneity of responses highlights the need for a treat-to-target protocol in the management of juvenile proliferative LN.

FRONTIERS IN PEDIATRICS (2022)

Add to Collection

Article Hematology

Treatment of inborn errors of immunity patients with inflammatory bowel disease phenotype by allogeneic stem cell transplantation

Laura M. Moser, Julia Fekadu, Andre Willasch, Eva Rettinger, Jan Soerensen, Andrea Jarisch, Marta Kirwil, Adrian Lieb, Dirk Holzinger, Gabriele Calaminus, Peter Bader, Shahrzad Bakhtiar

Summary: This study reports on the successful treatment of inborn errors of immunity (IEI) patients with treatment-refractory inflammatory bowel disease (IBD) using allogeneic hematopoietic stem cell transplantation (alloHSCT). The patients achieved stable engraftment, immune reconstitution, and resolution of gastrointestinal symptoms. The overall survival rate was 100% over a median follow-up of 34.7 months.

BRITISH JOURNAL OF HAEMATOLOGY (2023)

Add to Collection

Article Immunology

Phenotypic spectrum in recessive STING-associated vasculopathy with onset in infancy: Four novel cases and analysis of previously reported cases

Rensheng Wan, Johannes Faender, Ia Zakaraia, Min Ae Lee-Kirsch, Christine Wolf, Nadja Lucas, Lisa Isabel Olfe, Corinna Hendrich, Danny Jonigk, Dirk Holzinger, Mathis Steindor, Gunnar Schmidt, Claudia Davenport, Christian Klemann, Nicolaus Schwerk, Matthias Griese, Brigitte Schlegelberger, Florian Stehling, Christine Happle, Bernd Auber, Doris Steinemann, Martin Wetzke, Sandra von Hardenberg

Summary: This study reports four novel cases and eight historic cases of autosomal recessive SAVI caused by c.841C>T homozygosity. Comprehensive clinical data and treatment regimens are provided, and the study aims to raise awareness for autosomal recessive inheritance in this rare, severe disease, which may aid in early diagnosis and development of optimized treatment strategies.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Immunology

Update of evidence- and consensus-based guidelines for the treatment of juvenile idiopathic arthritis (JIA) by the German Society of Pediatric and Juvenile Rheumatic Diseases (GKJR): New perspectives on interdisciplinary care

Prasad T. Oommen, Timmy Strauss, Karen Baltruschat, Ivan Foeldvari, Christoph Deuter, Gerd Ganser, Johannes-Peter Haas, Claas Hinze, Dirk Holzinger, Anton Hospach, Hans-Iko Huppertz, Arnold Illhardt, Michael Jung, Tilmann Kallinich, Ariane Klein, Kirsten Minden, Kirsten Monkemoller, Sonja Mrusek, Ulrich Neudorf, Gregor Dueckers, Tim Niehues, Matthias Schneider, Philipp Schoof, Angelika Thon, Michael Wachowsky, Norbert Wagner, Susanne Bloedt, Michael Hofer, Klaus Tenbrock, Catharina Schuetz

Summary: This article summarizes the recent update of the interdisciplinary, consensus-based German guidelines on the management of juvenile idiopathic arthritis (JIA). Through multi-disciplinary and consensus participation, therapeutic principles and recommendations were proposed, providing physicians with evidence-based tailored treatment approaches.

CLINICAL IMMUNOLOGY (2022)

Add to Collection

Article Rheumatology

Aberrant Naive CD4-Positive T Cell Differentiation in Systemic Juvenile Idiopathic Arthritis Committed to B Cell Help

Julia Kuehn, Susanne Schleifenbaum, Michaela Hendling, Sandra Siebenhandl, Julie Krainer, Sabrina Fuehner, Antje Hellige, Carolin Park, Claas Hinze, Helmut Wittkowski, Dirk Holzinger, Lorenz Thurner, Andreas Weinhaeusel, Dirk Foell, Christoph Kessel

Summary: This study found that aberrant or incomplete polarization of T helper cells may contribute to the pathological processes in systemic juvenile idiopathic arthritis (sJIA).

ARTHRITIS & RHEUMATOLOGY (2023)

Add to Collection

Meeting Abstract Oncology

ETOPOSIDE FOR PRIMARY HLH - BETTER THAN ITS REPUTATION

Kai Lehmberg, Svea Ledig, Katharina Wustrau, Udo Kontny, Silke Westphal, Patrick Hundsdoerfer, Norbert Jorch, Johanna Scheer-Preiss, Dominik Schneider, Sujal Ghosh, Nora Naumann-Bartsch, Dirk Holzinger, Shahrzad Bakhtiar, Christine Mauz-Koerholz, Christof Kramm, Rita Beier, Wolfgang Behnisch, Monika Streiter, Alfred Laengler, Rhoikos Furtwaengler, Bernd Gruhn, Michaela Nathrath, Uemmueguel Behr, Meinolf Siepermann, Lars Fischer, Antje Redlich, Alexandra Russo, Matthias Duerken, Fabian Hauck, Martina Ahlmann, Martin Irnich, Heiko-Manuel Teltschik, Peter Lang, Manfred Hoenig, Ansgar Schulz, Sharon Choo, Bruce Crooks, Renata Formankova, Marianne Ifversen, Thais Murciano-Carrillo, Itziar Astigarraga, Juana Gil Herrera, Tal Ben-Ami, Joanne Yacobovich, Iwona Malinowska, Michael Jordan, Melissa Hines, Julie-An Talano, Jana Pachlopnik Schmid, Stephan Ehl

PEDIATRIC BLOOD & CANCER (2023)

Add to Collection

No Data Available

Calcium and zinc tune autoinflammatory Toll-like receptor 4 signaling by S100A12

Journal

Publisher

MOSBY-ELSEVIER

Keywords

Categories

Funding

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Export Citation

Share Paper